Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant mixed mesodermal tumours with peritoneal dissemination.
de Bree
E
E
Romanos
J
J
Relakis
K
K
Tsiftsis
D D
DD
D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D010478:Chemotherapy, Cancer, Regional Perfusion; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D006979:Hyperthermia, Induced; D007069:Ifosfamide / Q000008:administration & dosage; D007813:Laparotomy; D008099:Liver / Q000473:pathology; D016685:Mitomycin / Q000008:administration & dosage; D018198:Mixed Tumor, Malignant / Q000556:secondary* / Q000628:therapy*; D018199:Mixed Tumor, Mesodermal / Q000556:secondary* / Q000628:therapy*; D009364:Neoplasm Recurrence, Local / Q000628:therapy; D009367:Neoplasm Staging; D010529:Peritoneal Cavity / Q000473:pathology; D010534:Peritoneal Neoplasms / Q000473:pathology* / Q000628:therapy*; D016896:Treatment Outcome; D016387:Women's Health
D000903:Antibiotics, Antineoplastic; D018906:Antineoplastic Agents, Alkylating; D016685:Mitomycin; D007069:Ifosfamide